In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Newmont’s current price at $103.79 is significantly below its PERT-weighted fair value of $182.97, indicating notable undervaluation. Strong financial health scores and a highly confident DCF mid-value of $248.52 support substantial upside potential, though high Monte Carlo volatility (143.45% CV) signals elevated risk. Downside risk remains limited to 18.8%, underscoring asymmetric return potential.